BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9258601)

  • 1. Antisense regulation of oncogenes in human cancer.
    Mukhopadhyay T; Roth JA
    Crit Rev Oncog; 1996; 7(3-4):151-90. PubMed ID: 9258601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotides: the state of the art.
    Aboul-Fadl T
    Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense strategy: biological utility and prospects in the treatment of hematological malignancies.
    Warzocha K; Wotowiec D
    Leuk Lymphoma; 1997 Jan; 24(3-4):267-81. PubMed ID: 9156656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotides for cancer therapy-an overview.
    Stahel RA; Zangemeister-Wittke U
    Lung Cancer; 2003 Aug; 41 Suppl 1():S81-8. PubMed ID: 12867066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer gene suppression strategies: issues and potential.
    Passioura T; Symonds G
    Curr Issues Mol Biol; 2004 Jul; 6(2):89-101. PubMed ID: 15119820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense of oligonucleotides and the inhibition of oncogene expression.
    Prins J; de Vries EG; Mulder NH
    Clin Oncol (R Coll Radiol); 1993; 5(4):245-52. PubMed ID: 8398922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotides as therapeutics for malignant diseases.
    Ho PT; Parkinson DR
    Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense comes of age.
    Flanagan WM
    Cancer Metastasis Rev; 1998 Jun; 17(2):169-76. PubMed ID: 9770113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense therapy.
    Narayanan R; Akhtar S
    Curr Opin Oncol; 1996 Nov; 8(6):509-15. PubMed ID: 8971471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence.
    Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense therapy for cancer.
    Gleave ME; Monia BP
    Nat Rev Cancer; 2005 Jun; 5(6):468-79. PubMed ID: 15905854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
    Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical experience of antisense therapy for solid tumors.
    Webb MS; Zon G
    Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.
    Spänkuch B; Strebhardt K
    Curr Pharm Des; 2008; 14(11):1098-112. PubMed ID: 18473857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expression.
    Mercatante DR; Kole R
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):126-32. PubMed ID: 12084454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
    Calabretta B
    Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.